Long-term efficacy of a novel ribose-cross-linked collagen dermal filler: A histologic and histomorphometric study in an animal model

Sandu Pitaru, Matitiau Noff, Liat Blok, Eran Nir, Shahar Pitaru, Arie Goldlust, Naftali Savion

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: Degradation and loss of the three-dimensional shape are the major causes of limited functional longevity of dermal fillers made of natural polymers as collagen and hyaluronic acid. OBJECTIVE: This study assessed the functional longevity of a new ribose-cross-linked collagen filler during 24 months in an animal model. METHODS: Ribose-cross-linked collagen (Evolence, Colbar Life Sciences Ltd), glutaraldehyde-cross-linked collagen (Zyplast, Inamed Inc.), and non-cross-linked collagen (Zyderm, Inamed Inc.) were injected in the rabbit ear dermis. Biopsies obtained at 1, 6, 12, and 24 months were histomorphometrically assessed for shape preservation and cell repopulation. RESULT: The three-dimensional shape of Evolence remained stable during 24 months. Zyderm and Zyplast lost their three-dimensional shape after 6 months. Although the cell density in Evolence remained stable over time, that in Zyplast and Zyderm decreased significantly at 12 and 24 months. CONCLUSION: Ribose-cross-linked collagen is endowed with a higher functional longevity as assessed in an animal model when compared with the most used collagen-based dermal fillers.

Original languageEnglish
Pages (from-to)1045-1054
Number of pages10
JournalDermatologic Surgery
Volume33
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Dive into the research topics of 'Long-term efficacy of a novel ribose-cross-linked collagen dermal filler: A histologic and histomorphometric study in an animal model'. Together they form a unique fingerprint.

Cite this